Information Library

Results for: Endocrinology - Our Expertise

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Clinical Endpoint Committees

    White Paper — February 22, 2011
    As regulatory boards are expecting more from clinical endpoint committees, what guidance can you follow? This white paper sets forth current best practice for CECs.

  • Diabetes and Biomarkers

    Hear from the Experts — February 15, 2011
    The landscape is changing. Where do biomarkers fit in? Discover the current implications and challenges with biomarkers in the development of your diabetes portfolio in this peer reviewed commentary.

  • EMA’s Guidance on New Antidiabetic Drug Development

    White Paper — May 12, 2010
    Assessing the EMA’s Guidance on New Antidiabetic Drug Development In January 2010, the European Medicines Agency (EMA) issued a draft guideline on antidiabetic drug development

  • Bridging Cultures

    Case Study — May 9, 2010
    Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.

  • Data-Driven Patient Recruitment

    White Paper — March 23, 2010
    Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials.

Page 1 of 1 (5 results)

Subscribe to Email Based on Your Interests

Set preferences